Intra-Cellular Therapies (ITCI) Gains 5.38% for June 23

Equities Staff  |

Intra-Cellular Therapies Inc (NASDAQ:ITCI) stock was among today's market movers, finishing trading higher 5.38% to $57.19 on June 23.

813,268 shares were traded today compared to the 30-day daily average of 687,549 shares.

The company's stock has risen 3.69% so far in 2022.

Intra-Cellular Therapies shares have traded in a range between $28.40 and $66.00 over the past twelve months.

The company is set to release earnings on 2022-08-08.

For technical charts, analysis, and more on Intra-Cellular Therapies visit the company profile.

About Intra-Cellular Therapies Inc

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases.

To get more information on Intra-Cellular Therapies Inc and to follow the company's latest updates, you can visit the company's profile page here: Intra-Cellular Therapies Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content